How to make usage of the standardized EuroFlow 8-color protocols possible for instruments of different manufacturers.


Journal

Journal of immunological methods
ISSN: 1872-7905
Titre abrégé: J Immunol Methods
Pays: Netherlands
ID NLM: 1305440

Informations de publication

Date de publication:
12 2019
Historique:
received: 25 03 2017
accepted: 14 11 2017
pubmed: 21 11 2017
medline: 12 5 2020
entrez: 21 11 2017
Statut: ppublish

Résumé

A critical component of the EuroFlow standardization of leukemia/lymphoma immunophenotyping is instrument setup. Initially, the EuroFlow consortium developed a step-by-step standard operating protocol for instrument setup of ≥8-color flow cytometers that were available in 2006, when the EuroFlow activities started. Currently, there are 14 instruments from 9 manufacturers capable of 3-laser excitation and ≥8 color measurements. The specific adaptations required in the instrument set-up to enable them to acquire the standardized 8-color EuroFlow protocols are described here. Overall, all 14 instruments can be fitted with similar violet, blue and red lasers for simultaneous measurements of ≥8 fluorescent dyes. Since individual instruments differ both on their dynamic range (scale) and emission filters, it is not accurate to simply recalculate the target values to different scale, but adjustment of PMT voltages to a given emission filter and fluorochrome, is essential. For this purpose, EuroFlow has developed an approach using Type IIB (spectrally matching) particles to set-up standardized and fully comparable fluorescence measurements, in instruments from different manufacturers, as demonstrated here for the FACSCanto II, and Navios and MACSQuant flow cytometers. Data acquired after such adjustment on any of the tested cytometry platforms could be fully superimposed and therefore analyzed together. The proposed approach can be used to derive target values for any combination of spectrally distinct fluorochromes and any distinct emission filter of any new flow cytometry platform, which enables the measurement of the 8-color EuroFlow panels in a standardized way, by creating superimposable datafiles.

Identifiants

pubmed: 29154914
pii: S0022-1759(17)30139-4
doi: 10.1016/j.jim.2017.11.007
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

112388

Informations de copyright

Copyright © 2017. Published by Elsevier B.V.

Auteurs

Michaela Nováková (M)

CLIP - Childhood Leukaemia Investigation Prague, Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.

Hana Glier (H)

Kantonsspital Aarau, Aarau, Switzerland.

Naděžda Brdičková (N)

CLIP - Childhood Leukaemia Investigation Prague, Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.

Marcela Vlková (M)

Department of Clinical Immunology and Allergology, St. Anne's University Hospital in Brno, Czech Republic.

Ana Helena Santos (AH)

Laboratory of Flow Cytometry, Department of Hematology, Hospital de Santo António, Centro Hospitalar do Porto, Unidade Multidisciplinar de Investigação Biomédica (UMIB), Porto, Portugal.

Margarida Lima (M)

Laboratory of Flow Cytometry, Department of Hematology, Hospital de Santo António, Centro Hospitalar do Porto, Unidade Multidisciplinar de Investigação Biomédica (UMIB), Porto, Portugal.

Mikael Roussel (M)

Laboratoire d'Hématologie, Pôle Cellules et Tissus, CHU, INSERM UMR 1236, Rennes, France.

Juan Flores-Montero (J)

Cancer Research Centre (IBMCC, USAL-CSIC), Institute for Biomedical Research of Salamanca (IBSAL), Department of Medicine and Cytometry Service (NUCLEUS Research Support Platform), University of Salamanca (USAL), Salamanca and Centro de Investigación Biomédica en Red de Cáncer, Instituto Carlos III, Madrid, Spain.

Tomasz Szczepanski (T)

Department of Pediatric Hematology and Oncology, Zabrze Medical University of Silesia, Katowice, Poland.

Sebastian Böttcher (S)

University of Rostock, Division of Internal Medicine, Hematology laboratory, Medical Clinic III, Hematology, Oncology, and Palliative Medicine, Rostock, Germany.

Vincent H J van der Velden (VHJ)

Department of Immunology, Laboratory for Medical Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.

Paula Fernandez (P)

Kantonsspital Aarau, Aarau, Switzerland.

Ester Mejstříková (E)

CLIP - Childhood Leukaemia Investigation Prague, Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.

Leire Burgos (L)

Clínica Universidad de Navarra, Centro de Investigación Medica aplicada (CIMA), IDISNAm, Pamplona, Spain.

Bruno Paiva (B)

Clínica Universidad de Navarra, Centro de Investigación Medica aplicada (CIMA), IDISNAm, Pamplona, Spain.

Jacques J M van Dongen (JJM)

Department of Immunohematology and Blood Transfusion (IHB), Leiden University Medical Center (LUMC), Leiden, The Netherlands.

Alberto Orfao (A)

Cancer Research Centre (IBMCC, USAL-CSIC), Institute for Biomedical Research of Salamanca (IBSAL), Department of Medicine and Cytometry Service (NUCLEUS Research Support Platform), University of Salamanca (USAL), Salamanca and Centro de Investigación Biomédica en Red de Cáncer, Instituto Carlos III, Madrid, Spain.

Tomáš Kalina (T)

CLIP - Childhood Leukaemia Investigation Prague, Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic. Electronic address: tomas.kalina@lfmotol.cuni.cz.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH